New drug trial offers hope for advanced lung cancer patients
NCT ID NCT05949619
Summary
This early-stage trial is testing a new drug called BL-M02D1 in patients with advanced non-small cell lung cancer and other solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The study is for adults whose cancer has progressed despite prior therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.